Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (14138)
All Articles published online
|
Publishing Process of This Article
|
May 7, 2021 (publication date) through Jul 2, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Heda R, Yazawa M, Shi M, Bhaskaran M, Aloor FZ, Thuluvath PJ, Satapathy SK. Non-alcoholic fatty liver and chronic kidney disease: Retrospect, introspect, and prospect. World J Gastroenterol 2021; 27(17): 1864-1882 [PMID: 34007127 DOI: 10.3748/wjg.v27.i17.1864] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v27/i17/1864.htm |
| Number | Citing Articles |
| 1 |
Shiqi Hu, Xiaolan Li, Yuanyuan Sun, Shouling Wu, Yanqi Lan, Shuohua Chen, yanhong wang, Wei Liao, xiaomo wang, Di Zhang, Xiaojie Yuan, Jingli Gao, Li Wang. Short-Term Weight Loss Decreased the Risk of Chronic Kidney Disease in Incident NAFLD Participants: A Prospective Cohort. SSRN Electronic Journal 2021; doi: 10.2139/ssrn.3920905
|
| 2 |
Akash Roy, Anand V. Kulkarni. Ascites in patients with end-stage renal disease: Challenges and solutions from diagnosis to management. Hepatology Communications 2025; 9(4) doi: 10.1097/HC9.0000000000000687
|
| 3 |
Indrajit Bhattacharya, Deep Kumar Maity, Amit Kumar, Sampriti Sarkar, Teeshyo Bhattacharya, Amrita Sahu, Remya Sreedhar, Somasundaram Arumugam. Beyond obesity: lean metabolic dysfunction-associated steatohepatitis from unveiling molecular pathogenesis to therapeutic advancement. Naunyn-Schmiedeberg's Archives of Pharmacology 2025; doi: 10.1007/s00210-025-04257-x
|
| 4 |
Ming Yang, Shilu Luo, Jinfei Yang, Wei Chen, Liyu He, Di Liu, Li Zhao, Xi Wang. Crosstalk between the liver and kidney in diabetic nephropathy. European Journal of Pharmacology 2022; 931: 175219 doi: 10.1016/j.ejphar.2022.175219
|
| 5 |
Marina V. Maevskaya, Yulia V. Kotovskaya, Vladimir T. Ivashkin, Olga N. Tkacheva, Ekaterina A. Troshina, Marina V. Shestakova, Valeriy V. Breder, Natalia I. Geyvandova, Vladimir L. Doshchitsin, Ekaterina N. Dudinskaya, Ekaterina V. Ershova, Khava B. Kodzoeva, Ksenia A. Komshilova, Natalia V. Korochanskaya, Alexander Yu. Mayorov, Ekaterina E. Mishina, Maria Yu. Nadinskaya, Igor G. Nikitin, Nana V. Pogosova, Aida I. Tarzimanova, Minara Sh. Shamkhalova. The National Consensus statement on the management of adult patients with non-alcoholic fatty liver disease and main comorbidities. Terapevticheskii arkhiv 2022; 94(2): 216 doi: 10.26442/00403660.2022.02.201363
|
| 6 |
Mustafa Canbakan, Oguz Kagan Bakkaloglu, Kadri Atay, Emine Koroglu, Mehmet Murat Tuncer, Billur Canbakan, Hakan Senturk. The liver-kidney axis: Is serum leptin a potential link in non-alcoholic fatty liver disease-associated chronic kidney disease?. Arab Journal of Gastroenterology 2023; 24(1): 52 doi: 10.1016/j.ajg.2023.01.001
|
| 7 |
Muhammad Moseeb Ali Hashim, Muhammad Aizaz Mohsin Khan, Muhammad Usama Ashraf, Saniya Mohsin, Kamran Zahoor, Javeria Niazi, Aiza Khan, Sania Muzaffar, Madiha Makhdumi, Omar Ahmed Ibad, Talha Kamran Khan, Sohaib Khalid. Pathological Evolution and Internal Medicine Management of Nonalcoholic Fatty Liver Disease (NAFLD) in the Era of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Cureus 2025; doi: 10.7759/cureus.86963
|
| 8 |
V. T. Ivashkin, O. M. Drapkina, M. V. Maevskaya, K. L. Raikhelson, S. V. Okovityi, M. S. Zharkova, V. R. Grechishnikova, D. I. Abdulganieva, S. A. Alekseenko, M. D. Ardatskaya, I. G. Bakulin, N. V. Bakulina, P. O. Bogomolov, V. V. Breder, E. V. Vinnitskaya, N. I. Geyvandova, E. V. Golovanova, V. B. Grinevich, V. L. Doshchitsin, E. N. Dudinskaya, E. V. Ershova, K. B. Kodzoeva, I. V. Kozlova, K. A. Komshilova, Yu. V. Konev, N. V. Korochanskaya, Yu. V. Kotovskaya, Yu. A. Kravchuk, I. D. Loranskaya, I. V. Maev, A. I. Martynov, S. N. Mekhtiev, E. E. Mishina, M. Yu. Nadinskaia, I. G. Nikitin, M. F. Osipenko, O. D. Ostroumova, Ch. S. Pavlov, N. V. Pogosova, V. G. Radchenko, G. E. Roytberg, R. G. Saifutdinov, A. A. Samsonov, P. V. Seliverstov, S. I. Sitkin, L. V. Tarasova, A. I. Tarzimanova, O. N. Tkacheva, E. I. Tkachenko, E. A. Troshina, S. V. Turkina, Yu. P. Uspenskiy, Yu. A. Fominykh, O. V. Khlynova, Yu. V. Tsyganova, M. Sh. Shamkhalova, O. O. Sharkhun, M. V. Shestakova. Clinical Guidelines of the Russian Society for the Study of the Liver, Russian Gastroenterological Association, Russian Society for the Prevention of Non-Communicable Diseases, Russian Association of Endocrinologists, Russian Scientific Medical Society of Therapists, National Society of Preventive Cardiology, Russian Association of Gerontologists and Geriatricians on Non-Alcoholic Fatty Liver Disease. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2025; 35(1): 94 doi: 10.22416/1382-4376-2025-35-1-94-152
|
| 9 |
Shiqi Hu, Xiaolan Li, Yuanyuan Sun, Shouling Wu, Yanqi Lan, Shuohua Chen, Yanhong Wang, Wei Liao, Xiaomo Wang, Di Zhang, Xiaojie Yuan, Jingli Gao, Li Wang. Short‐term weight loss decreased the risk of chronic kidney disease in men with incident nonalcoholic fatty liver disease. Obesity 2022; 30(7): 1495 doi: 10.1002/oby.23459
|
| 10 |
Dongni Huang, Jing Ma, Yan Zhao, Qi Pan, Guogang Xu, Lixin Guo. Higher C-reactive protein to high-density lipoprotein cholesterol ratio is associated with hyperuricemia in diabetes and prediabetes: a cross-sectional study. Frontiers in Endocrinology 2025; 16 doi: 10.3389/fendo.2025.1619370
|
| 11 |
Lyudmila Kravchenko, Liana Unhurian, Svetlana Kotiuzhinska, Yana Ivanova, Maya Obrazenko, Liudmyla Zahorodnya, Tetiana Yamilova. Increasing the efficiency of hypolipidemic therapy with the combined use of quercetin in patients with non-alcoholic fatty liver disease on the background of the metabolic syndrome. Česká a slovenská farmacie 2023; 72(6): 296 doi: 10.5817/CSF2023-6-296
|
| 12 |
Yifan Li, Tiantian Sang, Naqiang Lv, Jinxing Liu, Yingzhen Gu, Xiaorong Han, Wei Zhang, Aimin Dang. The impact of uric acid on acute coronary syndrome prognosis in elderly patients. Annals of Medicine 2025; 57(1) doi: 10.1080/07853890.2024.2445200
|
| 13 |
Liana Iordan, Laura Gaita, Romulus Timar, Vlad Avram, Adrian Sturza, Bogdan Timar. The Renoprotective Mechanisms of Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i)—A Narrative Review. International Journal of Molecular Sciences 2024; 25(13): 7057 doi: 10.3390/ijms25137057
|
| 14 |
Qingwei Zhang, Wenjie Zhao, Zeqi Sun, Xinxin Dong, Liwei Zhu, Zhen Zhang, Ximing Chen, Yingying Hu, Menghan Du, Jiamin Li, Yong Zhang. Peroxisome proliferator-activated receptors gama ameliorates liver fibrosis in non-alcoholic fatty liver disease by inhibiting TGF-β/Smad signaling activation. Frigid Zone Medicine 2024; 4(1): 12 doi: 10.2478/fzm-2024-0002
|
| 15 |
Saleh Alqahtani, Rajaa Al-Raddadi, Ghada Ajabnoor, Zeyad Alraddadi, Jawaher Alahmadi, Adel Alhabash, Rehad Hakim, Loojen Alseraihi, Suhad Bahijri. Usefulness of Neck Circumference, Waist-to-Height Ratio and Waist-to-Hip Ratio in Predicting Non-Alcoholic Fatty Liver Disease in Saudi Population Without Type 2 Diabetes. Nutrition and Metabolic Insights 2024; 17 doi: 10.1177/11786388241259942
|
| 16 |
Yanan Zhao, Yingqian He, Lulu Zhang, Jing Liu, Yana Bai, Minzhen Wang, Shan Zheng. Effect of CVAI on the incidence of MASLD compared to BMI in populations with different body types: A prospective cohort study in China. Nutrition, Metabolism and Cardiovascular Diseases 2024; 34(2): 307 doi: 10.1016/j.numecd.2023.09.009
|
| 17 |
Therese Adrian, Mads Hornum, Filip Krag Knop, Karl Bang Christensen, Thomas Almdal, Peter Rossing, Lisa Í Lídaa, Niels Søndergaard Heinrich, Vincent Oltman Boer, Anouk Marsman, Esben Thade Petersen, Hartwig Roman Siebner, Bo Feldt-Rasmussen. Hepatic Fibrosis Evaluated in Patients with Type 2 Diabetes with and without Chronic Kidney Disease. Nephron 2023; 147(11): 673 doi: 10.1159/000531574
|
| 18 |
Kexin Lian, Qiming Fan, Sufang Sheng, Kexin Zhang, Xiaodong Sun, Chengxia Kan, Ruiyan Pan, Zhentao Guo. Metabolic Dysfunction-Associated Steatotic Liver Disease and Chronic Kidney Disease: Unraveling Connections and Advancing Therapies. Bratislava Medical Journal 2025; doi: 10.1007/s44411-025-00189-3
|
| 19 |
Tingting Qin, Mingliang Wang, Ting Zhang, Yingyu Wang, Yunyun Zhang, Muhammad Hasnat, Zirui Zhuang, Yongfang Ding, Yunru Peng. Total C-21 Steroidal Glycosides From Baishouwu Ameliorate Hepatic and Renal Fibrosis by Regulating IL-1β/MyD88 Inflammation Signaling. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.775730
|
| 20 |
O. V. Khlynova, N. S. Karpunina. Nonalcoholic fatty liver disease and chronic kidney disease: random connections or two manifestations of metabolic syndrome?. Experimental and Clinical Gastroenterology 2025; (8): 123 doi: 10.31146/1682-8658-ecg-228-8-123-130
|
| 21 |
V. T. Ivashkin, M. V. Maevskaya, M. S. Zharkova, Yu. V. Kotovskaya, O. N. Tkacheva, E. A. Troshina, M. V. Shestakova, I. V. Maev, V. V. Breder, N. I. Gheivandova, V. L. Doshchitsin, E. N. Dudinskaya, E. V. Ershova, Kh. B. Kodzoeva, K. A. Komshilova, N. V. Korochanskaya, A. Yu. Mayorov, E. E. Mishina, M. Yu. Nadinskaya, I. G. Nikitin, N. V. Pogosova, A. I. Tarzimanova, M. Sh. Shamkhalova. Clinical Practice Guidelines of the Russian Scientific Liver Society, Russian Gastroenterological Association, Russian Association of Endocrinologists, Russian Association of Gerontologists and Geriatricians and National Society for Preventive Cardiology on Diagnosis and Treatment of Non-Alcoholic Liver Disease. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2022; 32(4): 104 doi: 10.22416/1382-4376-2022-32-4-104-140
|
| 22 |
Jingrui Wang, Zhenzhen Su, Yijin Feng, Ruihan Xi, Jiamin Liu, Peixi Wang. Comparison of several blood lipid-related indexes in the screening of non-alcoholic fatty liver disease in women: a cross-sectional study in the Pearl River Delta region of southern China. BMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-02072-1
|
| 23 |
Fangli Zhou, Xiaoli He, Dan Liu, Yan Ye, Haoming Tian, Li Tian. Association between serum ferritin and uric acid levels and nonalcoholic fatty liver disease in the Chinese population. PeerJ 2023; 11: e16267 doi: 10.7717/peerj.16267
|
| 24 |
Aleksandra Klisić, Irena Radoman-Vujačić, Jelena Kostadinović, Ana Ninić. The correlation of metabolic and renal biomarkers with vitamin D status in postmenopausal women. Journal of Medical Biochemistry 2023; 42(4): 565 doi: 10.5937/jomb0-41044
|
| 25 |
Mihai-Emil Gherghina, Ileana Peride, Mirela Tiglis, Tiberiu Paul Neagu, Andrei Niculae, Ionel Alexandru Checherita. Uric Acid and Oxidative Stress—Relationship with Cardiovascular, Metabolic, and Renal Impairment. International Journal of Molecular Sciences 2022; 23(6): 3188 doi: 10.3390/ijms23063188
|
| 26 |
Minzhen Wang, Yanan Zhao, Yingqian He, Lulu Zhang, Jing Liu, Shan Zheng, Yana Bai. The bidirectional relationship between NAFLD and type 2 diabetes: A prospective population-based cohort study. Nutrition, Metabolism and Cardiovascular Diseases 2023; 33(8): 1521 doi: 10.1016/j.numecd.2023.05.018
|
| 27 |
Teresa Sierra, Brahim Achour. In Vitro to In Vivo Scalars for Drug Clearance in Nonalcoholic Fatty Liver and Steatohepatitis. Drug Metabolism and Disposition 2024; 52(5): 390 doi: 10.1124/dmd.123.001629
|
| 28 |
Shin Yamaoka, Kotomi Sasaki, Shin Sato. Curcumin intake during lactation suppresses oxidative stress through upregulation of nuclear factor erythroid 2‐related factor 2 in the kidneys of fructose‐loaded female rat offspring exposed to maternal protein restriction. Birth Defects Research 2023; 115(7): 674 doi: 10.1002/bdr2.2158
|
| 29 |
Rajiv Heda, Alexander J. Kovalic, Sanjaya K. Satapathy. Peritransplant Renal Dysfunction in Liver Transplant Candidates. Clinics in Liver Disease 2022; 26(2): 255 doi: 10.1016/j.cld.2022.01.010
|
| 30 |
Razvan George Bogdan, Adrian Boicean, Paula Anderco, Cristian Ichim, Mihai Iliescu-Glaja, Samuel Bogdan Todor, Elisa Leonte, Vlad Adam Bloanca, Zorin Petrisor Crainiceanu, Mirela Livia Popa. From Liver to Kidney: The Overlooked Burden of Nonalcoholic Fatty Liver Disease in Chronic Kidney Disease. Journal of Clinical Medicine 2025; 14(7): 2486 doi: 10.3390/jcm14072486
|
| 31 |
Niki Katsiki, Vasilios Athyros. Serum uric acid: a mediator of cardio-reno-metabolic diseases. Expert Review of Cardiovascular Therapy 2021; 19(12): 1127 doi: 10.1080/14779072.2021.2021071
|
| 32 |
Amedeo Lonardo, Alessandro Mantovani, Giovanni Targher, Gyorgy Baffy. Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease: Epidemiology, Pathogenesis, and Clinical and Research Implications. International Journal of Molecular Sciences 2022; 23(21): 13320 doi: 10.3390/ijms232113320
|
| 33 |
Zhixuan Lan, Yi Wei, Kan Yue, Ruilin He, Zongbin Jiang. Genetically predicted immune cells mediate the association between gut microbiota and neuropathy pain. Inflammopharmacology 2024; 32(5): 3357 doi: 10.1007/s10787-024-01514-y
|
| 34 |
Ying Che, Rongsong Tang, Heli Zhang, Min Yang, Rongmei Geng, Lin Zhuo, Peng Wang, Xianjing Hu, Yujie Zhou, Panfeng Wang, Siyan Zhan, Baohua Li. Development of a prediction model for predicting the prevalence of nonalcoholic fatty liver disease in Chinese nurses: the first-year follow data of a web-based ambispective cohort study. BMC Gastroenterology 2024; 24(1) doi: 10.1186/s12876-024-03121-1
|